Form 4/A for OKYO OKYO Pharma Ltd
Accepted 2026-08-07 16:15:32 ET · period of report 2026-07-20 · accession 0001493152-26-036582 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AI | 2026-08-07 16:15 | 2026-07-20 | OKYO | CERRONE GABRIELE M | Dir, 10% | P - Purchase | $1.40 | +25.0K | 10.85M | +0.2% | +$35.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2026-07-20 | P | A | 25,000 | $1.40 | 10,851,416 | I Via Panetta Partners Limited | — | — |